mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |